In skeletal muscle, LKB1 and AMPK enhance glucose transport, lipid and fatty acid oxidation, and insulin sensitivity, and may, therefore, be treatment targets for type 2 diabetes and obesity [50, 51]. The gene discussed is INS; the disease is type 2 diabetes mellitus.